arcadia

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE1420.9521.2 (+1.51 %)
PREV CLOSE ( ) 1399.75
OPEN PRICE ( ) 1408.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1045
TODAY'S LOW / HIGH ( )1392.00 1439.90
52 WK LOW / HIGH ( )882.55 1528
NSE1420.7518.95 (+1.35 %)
PREV CLOSE( ) 1401.80
OPEN PRICE ( ) 1400.05
BID PRICE (QTY) 1420.75 (30)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20926
TODAY'S LOW / HIGH( ) 1395.00 1431.00
52 WK LOW / HIGH ( )880.2 1528.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagan Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX
NEWS
22Jun AstraZeneca Pharma received Import, Ma
AstraZeneca Pharma India has received Import and Market permission in Fo..
22Jun AstraZeneca Pharma trades higher on re
Astrazeneca Pharma Indiais currently trading at Rs. 1402.55, up by 50.05..
21Jun Announcement under Regulation 30 (LOD
This is to inform that AstraZeneca Pharma India Limited has received Imp..
12Jun Clarification
With reference to increase in Volume, AstraZeneca Pharma India Ltd has s..
12Jun Clarification sought from AstraZeneca
The Exchange has sought clarification from AstraZeneca Pharma India Ltd..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit32.21259.15
Gross Profit 140.57 438
Operating Profit 176.08585.38
Net Sales 1507.275719.89
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7151.05 (1.67%)
M.Cap ( in Cr)15195.48
Piramal Enterprises (BSE)
 2556.50 (1.23%)
M.Cap ( in Cr)46169.82
Pfizer (BSE)
 2579.25 (1.11%)
M.Cap ( in Cr)11799.48
Zim Laboratories (BSE)
 350.00 (4.48%)
M.Cap ( in Cr)282.09
TTK Healthcare (BSE)
 761.65 (1.87%)
M.Cap ( in Cr)1076.24
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 17.08%
MUTUAL FUNDS/UTI 7.71%
FI/BANKS/INSURANCE 0.08%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM